Top 30 Companies in Global Oncology Clinical Trials Market (2025–2035): Competitive Analysis and Forecast
RELEASE DATE: Sep 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Oncology Clinical Trials Market Size is projected To Grow from USD 13.45 Billion in 2024 to USD 23.56 Billion by 2035, at a CAGR of 5.23% during the forecast period 2025
Introduction
The Oncology Clinical Trials Market Size is the global industry that performs controlled research studies to assess the safety, efficacy, and results of novel cancer therapies. These studies span many phases (I-IV) and target numerous cancer types, such as lung, breast, and leukemia, using both interventional and observational approaches. The market is developing as the global prevalence of cancer rises, driving the need for effective and diversified treatments. Patient-centric trial designs are redefining the landscape by emphasizing the participant experience, increasing efficiency, and fostering innovation. Rapid advances in personalized medicine, immunotherapies, targeted medicines, and cell- and gene-based treatments are expanding the options for cancer treatment. Furthermore, the incorporation of sophisticated technology and increasing regulatory frameworks enhances trial execution and data dependability. Growing investments from pharmaceutical corporations, biotechnology enterprises, contract research organizations (CROs), and non-profits are hastening medication discovery and therapeutic advances. These activities establish an atmosphere conducive to the worldwide expansion of cancer clinical trials. Collectively, these variables highlight the critical role of oncology clinical trials in generating creative, patient-centered, and effective solutions to fulfill the rising global need for new cancer therapies.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Oncology Clinical Trials Market.
Oncology Clinical Trials Market Size & Statistics
- The Market Size for Oncology Clinical Trials Was Estimated to be worth USD 13.45 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 5.23% between 2025 and 2035.
- The Global Oncology Clinical Trials Market Size is anticipated to reach USD 23.56 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Oncology Clinical Trials Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Oncology Clinical Trials Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Oncology Clinical Trials market. Asia Pacific is projected to grow at the fastest CAGR in the oncology clinical trials market, driven by its large and diverse population, rising cancer cases, cost-effective operations, favorable regulations, and improving healthcare infrastructure across key regional countries.
North America is expected to generate the highest demand during the forecast period in the Oncology Clinical Trials market. North America holds the highest share in the oncology clinical trials market, supported by advanced healthcare infrastructure, a strong research ecosystem, and NIH funding. The region’s developed pharmaceutical industry and focus on innovation make it a leading hub for global oncology trials.
Top 10 Trends in the Oncology Clinical Trials Market
- Precision and Personalized Medicine
- AI and Machine Learning
- Novel Immunotherapies
- Decentralized Clinical Trials (DCTs)
- Liquid Biopsies and Non-Invasive Monitoring
- Combination Therapies
- Targeting Undruggable Targets
- Focus on Diversity in Trials
- Real-World Evidence (RWE)
- Biopharma Innovation
1. Precision and Personalized Medicine
Oncology clinical trials are moving toward precision medicine, in which therapies are tailored to an individual's genetic composition, tumor biology, and lifestyle. This tailored strategy improves therapeutic results, decreases side effects, and provides more targeted cancer care, making trials more effective at offering novel, patient-centered therapy solutions.
2. AI and Machine Learning
AI and machine learning are revolutionizing cancer clinical trials by analyzing massive datasets to uncover trends, predict patient outcomes, and enhance trial design. These technologies increase efficiency, accelerate drug development, and improve decision-making, resulting in more accurate and effective cancer medicines at lower prices and schedules.
3. Novel Immunotherapies
Oncology clinical trials are increasingly evaluating innovative immunotherapies that engage the immune system to combat cancer. These treatments, which include checkpoint inhibitors and CAR-T cells, offer great promise in difficult-to-treat malignancies. Trials attempt to enhance efficacy, increase applicability, and improve safety, contributing to longer-lasting therapeutic outcomes for patients.
4. Decentralized Clinical Trials (DCTs)
Decentralized clinical trials in cancer use digital platforms, telemedicine, and remote monitoring to increase patient engagement. DCTs broaden trial access, boost enrollment diversity, and expedite data gathering, making trials more flexible, patient-friendly, and cost-effective while assuring high-quality outcomes.
5. Liquid Biopsies and Non-Invasive Monitoring
Liquid biopsies and non-invasive monitoring are gaining popularity in cancer clinical trials because they enable real-time surveillance of tumor biomarkers via blood samples. These tools advance customized cancer care by reducing the need for intrusive procedures, enabling early identification, monitoring therapy responses, and improving patient compliance.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the oncology clinical trials market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Oncology Clinical Trials Market
- AbbVie Inc.
- Sanofi
- Pivotal
- IQVIA Inc
- Medpace
- Novotech
- Astrazeneca
- Merck & Co., Inc
- Syneos Health
- PRA Health Sciences
- Gilead Sciences, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- PAREXEL International Corporation
- Novartis
- Pfizer Inc.
- Roche
- Bristol Myers Squibb
- Johnson & Johnson
- GlaxoSmithKline
- AbbVie Inc.
- Celgene Corporation
- Astellas Pharma Inc.
- Daiichi Sankyo
- Takeda Pharmaceutical Company Limited
1. AbbVie Inc.
Headquarters: North Chicago, Illinois, United States
AbbVie Inc., located in North Chicago, Illinois, operates in more than 70 countries and is a prominent player in the cancer clinical trials industry. The firm is involved in a wide spectrum of clinical trials, with a particular emphasis on targeted medicines and immuno-oncology. With a strong focus on developing medicines for hematologic malignancies and solid tumors, AbbVie uses its extensive worldwide R&D network to drive innovation. The company's oncology research strives to provide more effective and customized treatment choices, solving unmet medical requirements and improving patient outcomes, while growing its global footprint in cancer medication development.
2. Sanofi
Headquarters: Paris, France
Sanofi, based in Paris, France, operates in more than 100 countries and is a prominent competitor in the cancer clinical trials industry. The company actively performs clinical studies focused on novel therapeutics such as immuno-oncology, targeted medications, and combination treatments. Sanofi, with its global reach, works with research groups, institutions, and healthcare providers to enhance cancer research. Its oncology portfolio includes solid tumors and hematological malignancies, with a strong clinical development pipeline. By harnessing cutting-edge technology and strategic relationships, Sanofi hopes to speed the availability of new oncology therapies, improving outcomes for cancer patients globally.
3. IQVIA INC.
Headquarters: Durham, North Carolina, United States
IQVIA, based in Durham, North Carolina, USA, has operations in over 100 countries and is one of the world's largest clinical research firms. The organization is a key player in cancer clinical trials by combining sophisticated analytics, real-world data, and technology-driven solutions. IQVIA provides support for trials at all stages, with a focus on precision medicine, decentralized studies, and patient involvement initiatives. Its size enables it to manage complicated cancer initiatives ranging from biomarker-driven medicines to large-scale immuno-oncology trials. IQVIA accelerates oncology innovation by facilitating speedier recruiting, regulatory compliance, and operational efficiency, establishing it as a vital partner in worldwide cancer research advancement.
4. Pivotal
Headquarters: Madrid, Spain.
Pivotal, based in Madrid, Spain, operates globally, having a strong presence in Europe, the Americas, and Asia. Pivotal, a contract research company (CRO), supports cancer clinical trials through design, monitoring, data management, and regulatory compliance. The organization focuses on the effective implementation of interventional and observational research, ensuring that trials are patient-centred and scientifically sound. Pivotal works together with pharmaceutical, biotechnology, and academic organizations to develop innovative cancer therapies. Its cancer research experience helps to accelerate approvals and develop breakthrough medications, bringing new solutions to patients while improving the worldwide oncology clinical trial environment.
5. Medpace
Headquarters: Cincinnati, Ohio, United States
Medpace, located in Cincinnati, Ohio, works in over 40 countries and is a full-service clinical research business with a strong focus on cancer. The organization provides complete clinical trial services, including research design, site management, regulatory affairs, and statistical analysis. Medpace specializes in cancer studies that test innovative therapeutics such as immunotherapies, targeted treatments, and cell and gene therapies. Its global presence and therapeutic specialty enable it to provide sponsors with cost-effective, high-quality results. Medpace accelerates cancer research by combining scientific competence and operational efficiency, making a significant contribution to global oncology clinical development.
Are you ready to discover more about the oncology clinical trials market?
The report provides an in-depth analysis of the leading companies operating in the global Oncology clinical trials market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- AbbVie Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Sanofi
- IQVIA INC.
- Pivotal
- Medpace
- Novotech
- Astrazeneca
- Merck & Co., Inc
- Syneos Health
- Others.
Conclusion
The Global Oncology Clinical Trials Market Size is quickly developing, driven by rising cancer rates, advances in precision medicine, and the increased use of novel trial designs such as decentralized and patient-centric models. Pharmaceutical corporations, biotech businesses, contract research organizations, and academic institutions are all spending heavily on innovative medicines such as immunotherapies, targeted medications, and cell and gene therapies. North America leads because of its robust infrastructure; however, the Asia Pacific is experiencing rapid expansion due to enormous patient pools and economic benefits. Overall, more collaboration and technology integration would help to speed cancer research and improve patient outcomes throughout the world.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?